| Date Filed | Type | Description |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2019 |
4
| Saks Samuel R (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 126,050 options to buy
@ $3, valued at
$378.2k
|
|
| 05/16/2019 |
4
| Saks Samuel R (Chief Medical Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 45,000 options to buy
@ $10.8, valued at
$486k
|
|
| 03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2018 |
4
| Saks Samuel R (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Granted 20,000 options
@ $4.25, valued at
$85k
|
|
| 06/12/2018 |
4
| Saks Samuel R (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 54,348 shares
@ $2.76, valued at
$150k
|
|
| 05/31/2018 |
4
| Saks Samuel R (Chief Development Officer) has filed a Form 4 on Protagonist Therapeutics, Inc|
Txns:
| Granted 50,000 options to buy
@ $7.28, valued at
$364k
|
|
| 05/31/2018 |
3
| Saks Samuel R (Chief Development Officer) has filed a Form 3 on Protagonist Therapeutics, Inc |
| 03/09/2018 |
4
| Saks Samuel R (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Exercised 750 restricted stock units
@ $0
Exercised 750 restricted stock units
@ $0
Exercised 650 restricted stock units
@ $0 |
|
| 06/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/29/2016 |
4/A
| Saks Samuel R (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Bought 12,500 shares
@ $2, valued at
$25k
|
|
| 06/21/2016 |
4
| Saks Samuel R (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.|
Txns:
| Bought 25,000 shares
@ $2, valued at
$50k
|
|
| 06/03/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/20/2016 |
4
| Saks Samuel R (Director) has filed a Form 4 on DEPOMED INC|
Txns:
| Granted 7,669 options to buy
@ $19.16, valued at
$146.9k
Granted 3,131 options to buy
@ $0 |
|
| 05/13/2016 |
4
| Saks Samuel R (Director) has filed a Form 4 on DEPOMED INC|
Txns:
| Paid exercise price by delivering 734 shares
@ $17.52, valued at
$12.9k
|
|
| 02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/29/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/14/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 10/09/2012 |
4
| Saks Samuel R (Director) has filed a Form 4 on DEPOMED INC|
Txns:
| Granted 40,000 options
@ $6.17, valued at
$246.8k
|
|
| 10/09/2012 |
3
| Saks Samuel R (Director) has filed a Form 3 on DEPOMED INC |
| 10/28/2010 |
4
| Saks Samuel R (Director) has filed a Form 4 on Trubion Pharmaceuticals, Inc|
Txns:
| Disposed/sold 19,135 options to buy
@ $0.31, valued at
$5.9k
Disposed/sold 5,000 options to buy
@ $19.08, valued at
$95.4k
Disposed/sold 5,000 options to buy
@ $6.63, valued at
$33.2k
Disposed/sold 5,000 options to buy
@ $2.28, valued at
$11.4k
Disposed/sold 5,000 options to buy
@ $3.45, valued at
$17.3k
|
|
| 07/07/2009 |
4
| Saks Samuel R (Director) has filed a Form 4 on Cougar Biotechnology, Inc. |
| 05/28/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 01/23/2009 |
4
| Saks Samuel R (CEO) has filed a Form 4 on JAZZ PHARMACEUTICALS INC |
| 12/01/2008 |
4
| Saks Samuel R (CEO) has filed a Form 4 on JAZZ PHARMACEUTICALS INC |